Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 11/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 6/20 | 0.44 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.44 |
| ▸ | CNR1 | P21554 | 4/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8093648 | 0.91 | PTGS2 (0.54) | PTGS2PTGS1CNR1 | |
| SCHEMBL8094551 | 0.85 | CNR1 (0.49) | PTGS2PTGS1CNR1CA12CA1 | |
| SCHEMBL8093195 | 0.84 | PTGS2 (0.47) | PTGS2PTGS1CNR1CA12CA1 | |
| SCHEMBL8094547 | 0.83 | PTGS2 (0.60) | PTGS2PTGS1CNR1CA12CA1 | |
| SCHEMBL8094093 | 0.82 | CNR1 (0.46) | PTGS2PTGS1CNR1CA12CA1 | |
| SCHEMBL8095632 | 0.82 | PTGS2 (0.56) | PTGS2PTGS1CNR1CA12CA1 | |
| SCHEMBL8776744 | 0.81 | SQOR (0.46) | PTGS2PTGS1CHRNA7CNR1CA1 | |
| SCHEMBL8093983 | 0.81 | CNR1 (0.44) | PTGS2PTGS1CHRNA7CNR1CA12 | |
| SCHEMBL8092530 | 0.81 | PTGS2 (0.55) | PTGS2PTGS1CNR1CA12CA1 | |
| SCHEMBL8085721 | 0.81 | CNR1 (0.48) | PTGS2PTGS1CNR1CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0808304-B1 | 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION | SEARLE & CO (US) | 2000-12-27 | — | — | EP | disclosed |